Company coverage
Bliss GVS Pharma
What named news outlets reported about this company in the last 180 days. Headlines only, with a link to every story.
Tuesday 29 Sept
BusinessLine · via Google News ·
Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma
Tuesday 21 July
CNBC TV18 · via Google News ·
Anupam Rasayan launches open offer to acquire 26% stake in Bliss GVS Pharma at ₹299 per share
Wednesday 3 June
CNBC TV18 · via Google News ·
Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions
Moneycontrol · via Google News ·
Stocks to Watch Today: Infosys, Bliss GVS Pharma, Vedanta, John Cockerill, Concord Biotech, Rajnandini...
Sunday 24 May
Economic Times · via Google News ·
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Saturday 23 May
CNBC TV18 · via Google News ·
Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
BusinessLine · via Google News ·
Surat-based Anupam Rasayan India to acquire upto 74.2 per cent in Bliss GVS Pharma
Some headlines quote an analyst. Those views are theirs, not ours.
See 365 days of coverage.
Pro shows every headline our outlets wrote about this company in the last {days} days, and lets you search them.
- A year of coverage instead of 6 months
- Search every headline about this company
- Results-day digests and alerts
Try Pro free First month free. No card.